made by Flexion to. Third Parties in connection with fund raising or financings or a due diligence or similar investigations by such Third Parties, and disclosure to potential Third Party investors or financial institutions or advisors in financing documents, provided in each case that any such Third Party agrees to be bound by obligations of confidentiality and non-use on substantially similar terms as those set out in this Article 10. for a minimum period of three years. Notwithstanding the foregoing, in the event that either Party is required by Applicable Law or the requirements of a national securities exchange or another similar regulatory body to disclose this Agreement, in whole or in part, the Parties shall reasonably agree on a redacted version of this Agreement as necessary to protect the Confidential Information of the other Party prior to making such disclosure.
Appears in 3 contracts
Samples: Out Licence Agreement, Out Licence Agreement (Flexion Therapeutics Inc), Out Licence Agreement (Flexion Therapeutics Inc)
made by Flexion to. Third Parties in connection with fund raising or financings or a due diligence or similar investigations by such Third Parties, and disclosure to potential Third Party investors or financial institutions or advisors in financing documents, provided in each case that any such Third Party agrees to be bound by obligations of confidentiality and non-use on substantially similar terms as those set out in this Article 10. 11 for a minimum period of three years. Notwithstanding the foregoing, in the event that either Party is required by Applicable Law or the requirements of a national securities exchange or another similar regulatory body to disclose this Agreement, in whole or in part, the Parties shall reasonably agree on a redacted version of this Agreement as necessary to protect the Confidential Information of the other Party prior to making such disclosure.
Appears in 2 contracts
Samples: Out Licence Agreement (Flexion Therapeutics Inc), Out Licence Agreement (Flexion Therapeutics Inc)